THERAPEUTICSMD INC - COM (TXMD)

CUSIP: 88338N107

Q2 2016 13F Holders as of 30 Jun 2016

Type / Class
Equity / COM
Total 13F shares
160,166,119
Share change
+7,219,344
Total reported value
$1,361,401,786
Put/Call ratio
67%
Price per share
$8.50
Number of holders
122
Value change
+$63,580,566
Number of buys
65
Number of sells
48

Quarterly Holders Quick Answers

What is CUSIP 88338N107?
CUSIP 88338N107 identifies TXMD - THERAPEUTICSMD INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of THERAPEUTICSMD INC - COM (TXMD) as of Q2 2016

As of 30 Jun 2016, THERAPEUTICSMD INC - COM (TXMD) was held by 122 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 160,166,119 shares. The largest 10 holders included FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, PRICE T ROWE ASSOCIATES INC /MD/, Bank of New York Mellon Corp, JPMORGAN CHASE & CO, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, GILDER GAGNON HOWE & CO LLC, BlackRock Fund Advisors, and BlackRock Institutional Trust Company, N.A.. This page lists 122 institutional shareholders reporting positions in this security for the Q2 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.